Please use this identifier to cite or link to this item:
|Title:||Umbilical cord blood banking: Beyond the public-private divide|
|Authors:||O'Connor, MA;Samuel, G;Jordens, C;Kerridge, I|
|Description:||Umbilical cord blood is a source of haematopoietic progenitor cells, which are used to treat a range of malignant, genetic, metabolic and immune disorders. Until recently, cord blood was either collected through donations to publicly funded cord blood banks for use in allogeneic transplantation, or stored in commercial cord blood banks for use in autologous transplantation. The line between public and private cord blood banking is being blurred by the emergence of "hybrid" models that combine aspects of both the public and private systems. The authors describe these hybrid models and argue that their emergence is explained by both market forces and public sector policy They propose that the future of the sector will depend heavily on several key developments that will differentially affect public, private and hybrid banking models.|
|Standard no:||O'Connor M, Samuel G, Jordens C, Kerridge I. Umbilical cord blood banking: Beyond the public-private divide. J Law Medicine. 2012;19:512-6.|
|Type Of Material:||Article|
|Appears in Collections:||Sydney School of Public Health|
Files in This Item:
Click on the URI links for accessing contents.
Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.